SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Efficacy and safety of eszopiclone across 6-weeks of treatment for primary insomnia
5 references·16 citing·43 second hop
Efficacy and safety of eszopiclone across 6-weeks of treatment for primary insomnia (2004)Efficacy and safety of eszopiclone across…Sustained Efficacy of Eszopiclone Over 6 Months of Nightly Treatment: Results of a Randomized, Double-Blind, Placebo-Controlled Study in Adults with Chronic Insomnia (2003)Sustained Efficacy of Eszopic…Epidemiology of insomnia: what we know and what we still need to learn (2002)Epidemiology of insomnia: wha…Characteristics of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. I. (1999)Characteristics of insomnia i…Daytime Alertness in Patients with Chronic Insomnia Compared with Asymptomatic Control Subjects (1988)Daytime Alertness in Patients…Insomnia and Its Treatment (1985)Insomnia and Its TreatmentThe impact of cognitive behavioural therapy for insomnia on objective sleep parameters: A meta-analysis and systematic review (2019)The impact of cognitive behav…The assessment and management of insomnia: an update (2019)The assessment and management…Pharmacologic Treatment of Insomnia Disorder: An Evidence Report for a Clinical Practice Guideline by the American College of Physicians (2016)Pharmacologic Treatment of In…Pharmacological Treatment of Insomnia. (2015)Pharmacological Treatment of …Drug Treatment of Primary Insomnia: A Meta-Analysis of Polysomnographic Randomized Controlled Trials (2014)Drug Treatment of Primary Ins…In the Zzz Zone: The Effects of Z-Drugs on Human Performance and Driving (2013)In the Zzz Zone: The Effects …Orexin Receptor Antagonism, a New Sleep-Enabling Paradigm: A Proof-of-Concept Clinical Trial (2012)Orexin Receptor Antagonism, a…Efficacy and Safety of Doxepin 3 and 6 mg in a 35-day Sleep Laboratory Trial in Adults with Chronic Primary Insomnia (2011)Efficacy and Safety of Doxepi…Searching for perfect sleep: the continuing evolution of GABA A receptor modulators as hypnotics (2009)Searching for perfect sleep: …Eszopiclone improves insomnia and depressive and anxious symptoms in perimenopausal and postmenopausal women with hot flashes: a randomized, double-blinded, placebo-controlled crossover trial (2009)Eszopiclone improves insomnia…A compendium of placebo-controlled trials of the risks/benefits of pharmacological treatments for insomnia: The empirical basis for U.S. clinical practice (2009)A compendium of placebo-contr…Eszopiclone Coadministered With Escitalopram in Patients With Insomnia and Comorbid Generalized Anxiety Disorder (2008)Eszopiclone Coadministered Wi…Evaluation of the Efficacy and Safety of Ramelteon in Subjects with Chronic Insomnia (2007)Evaluation of the Efficacy an…Therapeutic Options for Sleep‐Maintenance and Sleep‐Onset Insomnia (2006)Therapeutic Options for Sleep…Sleep Maintenance Insomnia: Strengths and Weaknesses of Current Pharmacologic Therapies (2006)Sleep Maintenance Insomnia: S…An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia (2005)An evaluation of the efficacy…Epidemiologic Study of Sleep Disturbances and Psychiatric Disorders (1989)Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? (1989)Psychological And Behavioral Treatment Of Insomnia: Update Of The Recent Evidence (1998–2004) (2006)Review of the histamine system and the clinical effects of H1 antagonists: Basis for a new model for understanding the effects of insomnia medications (2013)Pharmacotherapy Treatment Options for Insomnia: A Primer for Clinicians (2015)Effectiveness of Sequential Psychological and Medication Therapies for Insomnia Disorder (2020)Sleep disturbance and psychiatric disorders: A longitudinal epidemiological study of young Adults (1996)Behavioral and Pharmacological Therapies for Late-Life Insomnia (1999)Long-Term Efficacy and Safety of Zolpidem Extended-Release 12.5 mg, Administered 3 to 7 Nights Per Week for 24 Weeks, in Patients With Chronic Primary Insomnia: A 6-Month, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study (2008)Insomnia: prevalence, consequences and effective treatment (2013)Chronic Insomnia Is Associated with Nyctohemeral Activation of the Hypothalamic-Pituitary-Adrenal Axis: Clinical Implications (2001)Recommendations on Evidence Needed to Support Measurement Equivalence between Electronic and Paper-Based Patient-Reported Outcome (PRO) Measures: ISPOR ePRO Good Research Practices Task Force Report (2008)Efficacy of Brief Behavioral Treatment for Chronic Insomnia in Older Adults (2011)Diagnostic and Statistical Manual of Mental Disorders (2013)Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial (2014)Visual analogue scales: measurement of subjective phenomena. (1989)Insomnia: Epidemiology, characteristics, and consequences (2003)An efficacy, safety, and dose–response study of Ramelteon in patients with chronic primary insomnia (2005)Efficacy and Safety of 6-Month Nightly Ramelteon Administration in Adults with Chronic Primary Insomnia (2009)Next-Day Effects of Ramelteon (8 mg), Zopiclone (7.5 mg), and Placebo on Highway Driving Performance, Memory Functioning, Psychomotor Performance, and Mood in Healthy Adult Subjects (2011)Sleep in Older Adults (2014)Measuring inconsistency in meta-analyses (2003)Clinical Guideline for the Evaluation and Management of Chronic Insomnia in Adults (2008)DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS, FIFTH EDITION (2013)Mindfulness meditation for insomnia: A meta-analysis of randomized controlled trials (2016)Insomnia in Elderly Patients: Recommendations for Pharmacological Management (2018)The European Academy for Cognitive Behavioural Therapy for Insomnia: An initiative of the European Insomnia Network to promote implementation and dissemination of treatment (2019)The Pittsburgh sleep quality index: A new instrument for psychiatric practice and research (1989)A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale (1991)Diagnostic and Statistical Manual of Mental Disorders (2013)Clinical pharmacology, efficacy, and safety of orexin receptor antagonists for the treatment of insomnia disorders (2020)The Impact of the COVID-19 Pandemic on Students’ Mental Health and Sleep in Saudi Arabia (2021)Long-Term Safety and Tolerability of Daridorexant in Patients with Insomnia Disorder (2022)Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy (1994)Epidemiology of Insomnia, Depression, and Anxiety (2005)Sleep Disturbance, Sleep Duration, and Inflammation: A Systematic Review and Meta-Analysis of Cohort Studies and Experimental Sleep Deprivation (2015)European guideline for the diagnosis and treatment of insomnia (2017)Chronic Insomnia and the Stress System (2007)Insomnia: Prevalence, Impact, Pathogenesis, Differential Diagnosis, and Evaluation (2008)The relationship between insomnia and body temperatures (2008)Sleep disturbance in cancer patients (2002)Sleep disturbances, work stress and work hours (2002)Use of sleep hygiene in the treatment of insomnia (2003)
this work references cited by second hop

References

  • 2002Epidemiology of insomnia: what we know and what we still need to learn3,741 cited
  • 1985Insomnia and Its Treatment1,071 cited
  • 1999Characteristics of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. I.776 cited
  • 2003Sustained Efficacy of Eszopiclone Over 6 Months of Nightly Treatment: Results of a Randomized, Double-Blind, Placebo-Controlled Study in Adults with Chronic Insomnia630 cited
  • 1988Daytime Alertness in Patients with Chronic Insomnia Compared with Asymptomatic Control Subjects303 cited

Cited by

  • 2016Pharmacologic Treatment of Insomnia Disorder: An Evidence Report for a Clinical Practice Guideline by the American College of Physicians274 cited
  • 2019The assessment and management of insomnia: an update255 cited
  • 2005An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia230 cited
  • 2007Evaluation of the Efficacy and Safety of Ramelteon in Subjects with Chronic Insomnia197 cited
  • 2009A compendium of placebo-controlled trials of the risks/benefits of pharmacological treatments for insomnia: The empirical basis for U.S. clinical practice179 cited
  • 2013In the Zzz Zone: The Effects of Z-Drugs on Human Performance and Driving177 cited
  • 2019The impact of cognitive behavioural therapy for insomnia on objective sleep parameters: A meta-analysis and systematic review171 cited
  • 2009Searching for perfect sleep: the continuing evolution of GABA A receptor modulators as hypnotics

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

163 cited
  • 2008Eszopiclone Coadministered With Escitalopram in Patients With Insomnia and Comorbid Generalized Anxiety Disorder158 cited
  • 2006Sleep Maintenance Insomnia: Strengths and Weaknesses of Current Pharmacologic Therapies137 cited
  • 2014Drug Treatment of Primary Insomnia: A Meta-Analysis of Polysomnographic Randomized Controlled Trials136 cited
  • 2011Efficacy and Safety of Doxepin 3 and 6 mg in a 35-day Sleep Laboratory Trial in Adults with Chronic Primary Insomnia129 cited
  • 2012Orexin Receptor Antagonism, a New Sleep-Enabling Paradigm: A Proof-of-Concept Clinical Trial126 cited
  • 2006Therapeutic Options for Sleep‐Maintenance and Sleep‐Onset Insomnia122 cited
  • 2015Pharmacological Treatment of Insomnia.109 cited
  • 2009Eszopiclone improves insomnia and depressive and anxious symptoms in perimenopausal and postmenopausal women with hot flashes: a randomized, double-blinded, placebo-controlled crossover trial106 cited